Pancreatic Cancer – Low Survival Rates

Interpreting cancer survival rates.

Survival rates associated with in vitro low-temperature storage of kutum (Rutilus kutum) eggs

To study the effects of post-stripping oocyte ageing at low temperatures on the viability of kutum (Rutilus kutum) oocytes, unfertilised eggs of five females were stored in ovarian fluid at temperatures of 4 and 7 degree centigrade for 24 hours post stripping (HPS). The stored ova of five female kutum were separately fertilised at 0 (i.e., control eggs fertilised prior to storage), 4, 8, 12, 16...

Survival rates associated with in vitro low-temperature storage of kutum (Rutilus kutum) eggs

To study the effects of post-stripping oocyte ageing at low temperatures on the viability of kutum (Rutilus kutum) oocytes, unfertilised eggs of five females were stored in ovarian fluid at temperatures of 4 and 7 degree centigrade for 24 hours post stripping (HPS). The stored ova of five female kutum were separately fertilised at 0 (i.e., control eggs fertilised prior to storage), 4, 8, 12, 16...

New approaches tackle rising pancreatic cancer rates.

Taking the immunomodulator simtuzumab with gemcitabine did not statistically significantly increase progression-free survival in advanced pancreatic cancer, according to a phase II study. Simtuzumab’s maker, Gilead Sciences (Foster City, Calif.), reported results of the double-blind randomized trial of 236 patients in September. Stromal targeting is one of several new approaches to treating thi...

Very long-term survival in pancreatic cancer

ductal adenocarcinoma (PDAC) is often perceived as an incurable disease by both patients and their physicians. While the outcome of most solid tumors has improved over the last 20 years, the median survival for patients with PDAC has steadily remained less than 12 months, even with the best therapeutic regimens currently available [1]. Despite the discouraging statistics, approximately 20% of a...